Sign In
Buy JNJ
$244.88
+3.88 (+1.61%)
At Close: Jun 25, 2026
Here's Why Johnson & Johnson (JNJ) Fell More Than Broader Market
06:56pm, Monday, 08'th Apr 2024
In the latest trading session, Johnson & Johnson (JNJ) closed at $151.59, marking a -0.52% move from the previous day.
Johnson & Johnson to Participate in the 2024 RBC Capital Markets Global Healthcare Conference
06:06pm, Monday, 08'th Apr 2024
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will participate in the 2024 RBC Capital Markets Global Healthcare Conference on Wednesday, May 15th, at the InterContinental Barcla
Will the Shockwave Medical Deal Be the Jolt JNJ Stock Needs?
11:55am, Monday, 08'th Apr 2024
On April 5, 2024, Johnson & Johnson NYSE: JNJ announced its intent to acquire Shockwave Medical Inc. NASDAQ: SWAV for $13.1 billion. Under the terms of the proposed deal, JNJ will pay $335 per share,
FDA Expands J&J's (JNJ) Carvykti Label in Multiple Myeloma
10:41am, Monday, 08'th Apr 2024
Following the label expansion, J&J's (JNJ) Carvykti is approved as a second-line treatment for adults with relapsed/refractory myeloma. It was initially approved for use as a fifth- or later-line trea
J&J's (JNJ) $13.1B Shockwave Deal to Boost MedTech Cardio
10:21am, Monday, 08'th Apr 2024
J&J's (JNJ) proposed acquisition of Shockwave Medical (SWAV) is expected to strengthen its Medtech cardiovascular portfolio.
Is Johnson & Johnson Stock A Better Pick Over AbbVie?
07:30am, Monday, 08'th Apr 2024
We believe that the pharmaceuticals bellwether Johnson & Johnson (NYSE: JNJ) is currently a better pick over its peer AbbVie (NYSE: ABBV). AbbVie ABBV trades at a higher valuation of 5.5x trailing rev
U.S. IPO Weekly Recap: April IPO Market Gets A Boost From Large Launches And New Filings
05:50am, Saturday, 06'th Apr 2024
U.S. IPO Weekly Recap: April IPO Market Gets A Boost From Large Launches And New Filings
U.S. FDA approves expanded use of J&J's cancer cell therapy
11:43pm, Friday, 05'th Apr 2024
The U.S. Food and Drug Administration on Friday allowed the expanded use of Johnson & Johnson and Legend Biotech's Carvykti cell therapy as an earlier treatment for patients with a type of blood cance
Acquisition Watch: Time to Buy Johnson & Johnson (JNJ) or ShockWave Medical's (SWAV) Stock?
04:31pm, Friday, 05'th Apr 2024
News of healthcare behemoth Johnson & Johnson (JNJ) acquiring medical device company ShockWave Medical (SWAV) for $13.1 billion made headlines this morning.
J&J Acquires Shockwave Medical to Boost Its Cardiovascular Treatment Portfolio
12:25pm, Friday, 05'th Apr 2024
Johnson & Johnson (JNJ) announced Friday it was buying Shockwave Medical (SWAV) for $13.1 billion in cash, pushing shares of the maker of cardiovascular catheters to near all-time highs.
Johnson & Johnson to acquire medical device company Shockwave Medical for $13.1B
11:12am, Friday, 05'th Apr 2024
Johnson & Johnson (NYSE:JNJ) (J&J) will bolster its portfolio of medical devices targeting heart disease with its $13.1 billion acquisition of Shockwave Medical. The companies announced on Friday tha
Shockwave Medical Stock Rises After Johnson & Johnson Buyout
11:05am, Friday, 05'th Apr 2024
Shockwave Medical Inc (NASDAQ:SWAV) is in the spotlight today, after blue-chip pharmaceutical giant Johnson & Johnson (JNJ) announced it would buy the company for $12.5 billion, boosting its portfol
Johnson & Johnson to Buy Shockwave Medical in $13.1 Billion Deal
10:33am, Friday, 05'th Apr 2024
The healthcare giant said the addition of the medical-device maker would expand its MedTech cardiovascular portfolio.
Johnson & Johnson Buys Shockwave For $13.1 Billion In Latest Cardio Deal
10:01am, Friday, 05'th Apr 2024
Johnson & Johnson will acquire Shockwave Medical in a deal valued at $13.1 billion, according to a joint statement Friday, the latest acquisition by the pharmaceutical firm over the last two years as
SWAV Stock Alert: Shockwave Medical Lands Big Buyer in Johnson & Johnson
09:31am, Friday, 05'th Apr 2024
Johnson & Johnson (NYSE: JNJ ) is buying medical device company Shockwave Medical (NASDAQ: SWAV ) for $13.1 billion. Shockwave makes devices that perform Intravascular Lithotripsy.
